BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 34154843)

  • 1. Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Single Case.
    Li Y; Chen J; Niu S
    Int J Gynecol Pathol; 2024 May; 43(3):271-274. PubMed ID: 37922950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological overview of endometrial endometrioid carcinoma.
    Maher M; Zeches BA; Mohamed A
    Int J Gynecol Cancer; 2024 Apr; 34(4):645-647. PubMed ID: 37852674
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexistence of homologous-type cervical carcinosarcoma with endometrioid-type G1 endometrial cancer: a case report with an immunohistochemical study.
    Semczuk A; Colas E; Walczyna B; Joźwik M; Pyra A; Semczuk-Sikora A; Rechberger T
    Int J Clin Exp Pathol; 2014; 7(10):7191-5. PubMed ID: 25400816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
    Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
    Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.
    Angelico G; Salvatorelli L; Tinnirello G; Santoro A; Zannoni GF; Puzzo L; Magro G
    Histopathology; 2024 May; 84(6):1068-1070. PubMed ID: 38173293
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites.
    Stewart CJR; Crum CP; McCluggage WG; Park KJ; Rutgers JK; Oliva E; Malpica A; Parkash V; Matias-Guiu X; Ronnett BM
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S75-S92. PubMed ID: 30550485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Cancer Progression of Non-Atypical Endometrial Hyperplasia.
    Rotenberg O
    Obstet Gynecol; 2023 Dec; 142(6):1496-1499. PubMed ID: 37917950
    [No Abstract]   [Full Text] [Related]  

  • 9. Endometrioid type adenocarcinoma in situ as a potential precursor lesion for extremely rare invasive endometrioid type adenocarcinoma of the cervix.
    Zannoni GF; Santoro A; Addante F; Cianfrini F; Stolnicu S
    Pathol Res Pract; 2024 Feb; 254():155062. PubMed ID: 38199133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesonephric-like adenocarcinoma of the endometrium: A case report.
    He J; Di XQ; Zhang N; Huang JZ
    Asian J Surg; 2024 Mar; 47(3):1680-1682. PubMed ID: 38182512
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma.
    Silverberg SG
    Mod Pathol; 2000 Mar; 13(3):309-27. PubMed ID: 10757341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature.
    Rakha E; Wong SC; Soomro I; Chaudry Z; Sharma A; Deen S; Chan S; Abu J; Nunns D; Williamson K; McGregor A; Hammond R; Brown L
    Am J Surg Pathol; 2012 Nov; 36(11):1683-90. PubMed ID: 23073327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.